| Basics |
IQVIA Holdings Inc.
IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
|
| IPO Date: |
May 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$24.31B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.13 | 1.18%
|
| Avg Daily Range (30 D): |
$2.38 | 1.61%
|
| Avg Daily Range (90 D): |
$2.89 | 1.72%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.01M |
| Avg Daily Volume (30 D): |
1.99M |
| Avg Daily Volume (90 D): |
1.61M |
| Trade Size |
| Avg Trade Size (Sh.): |
56 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
50 |
| Institutional Trades |
| Total Inst.Trades: |
8,139 |
| Avg Inst. Trade: |
$11.27M |
| Avg Inst. Trade (30 D): |
$17.56M |
| Avg Inst. Trade (90 D): |
$17.13M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$28.14M |
| Avg Closing Trade (30 D): |
$42.71M |
| Avg Closing Trade (90 D): |
$43.5M |
| Avg Closing Volume: |
156.09K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$1.42
|
$2.43
|
$7.57
|
|
Diluted EPS
|
$1.4
|
$2.41
|
$7.49
|
|
Revenue
|
$ 3.83B
|
$ 3.96B
|
$ 15.41B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 249M
|
$ 437M
|
$ 1.37B
|
|
Operating Income / Loss
|
$ 496M
|
$ 626M
|
$ 2.2B
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 38M
|
$ 130M
|
$ 326M
|
|
PE Ratio
|
99.52
|
|
|
|
